We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

58 hedge funds and large institutions have $272M invested in Audentes Therapeutics, Inc in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

2% more funds holding

Funds holding: 57 → 58 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less capital invested

Capital invested by funds: $283M → $272M (-$10.8M)

Holders
58
Holders Change
+1
Holders Change %
+1.75%
% of All Funds
1.44%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
19
Reduced
15
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.9M
2
CC
Casdin Capital
New York
+$4.21M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.76M
4
Victory Capital Management
Victory Capital Management
Texas
+$728K
5
SIM
Spark Investment Management
New York
+$448K

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$748K
2
CAM
Cormorant Asset Management
Massachusetts
-$404K
3
RI
RTW Investments
New York
-$365K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$307K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$294K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$756K +$25.7K +1,591 +4%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$578K +$225K +13,934 +70%
SIM
28
Spark Investment Management
New York
$472K +$448K +27,700 New
TD Asset Management
29
TD Asset Management
Ontario, Canada
$421K +$228K +14,082 +133%
Bank of America
30
Bank of America
North Carolina
$399K +$69.7K +4,310 +23%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$321K +$81K +5,009 +36%
Goldman Sachs
32
Goldman Sachs
New York
$313K -$5.05K -312 -2%
PPA
33
Parametric Portfolio Associates
Washington
$291K -$6.31K -390 -2%
AAP
34
Ardsley Advisory Partners
Connecticut
$214K +$203K +12,572 New
ProShare Advisors
35
ProShare Advisors
Maryland
$209K -$48.8K -3,020 -20%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$201K – – –
TCIM
37
TIAA CREF Investment Management
New York
$197K -$5.4K -334 -3%
Citadel Advisors
38
Citadel Advisors
Florida
$184K +$175K +10,815 New
Charles Schwab
39
Charles Schwab
California
$183K – – –
Morgan Stanley
40
Morgan Stanley
New York
$156K -$123K -7,593 -45%
Wells Fargo
41
Wells Fargo
California
$132K +$92.2K +5,700 +278%
PA
42
Perceptive Advisors
New York
$128K – – –
TA
43
Teachers Advisors
New York
$104K – – –
Barclays
44
Barclays
United Kingdom
$91K +$65.2K +4,030 +300%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$70K +$35.6K +2,201 +116%
AIG
46
American International Group
New York
$58K +$54.8K +3,385 New
NFA
47
Nationwide Fund Advisors
Ohio
$38K +$35.7K +2,210 New
SO
48
STRS Ohio
Ohio
$30K – – –
Deutsche Bank
49
Deutsche Bank
Germany
$25K -$39.3K -2,428 -61%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$20K +$17.2K +1,063 +1,296%
1
2
3

BOLD Hedge Fund Activity: Q1 2017 in Review

58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q1 2017, worth a combined $272M — down 3.8% from $283M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BOLD positions and 2 closed out — a net gain of 7 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $13.9M. The largest seller was AllianceBernstein, cutting an estimated $748K.

  • 58 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q1 2017, up from 57 in Q4 2016.
  • Funds reported $272M of Audentes Therapeutics, Inc stock for Q1 2017, down 3.8% quarter-over-quarter.
  • 9 funds opened new Audentes Therapeutics, Inc positions in Q1 2017 and 2 closed out, a net change of +7 holders.
  • The largest Audentes Therapeutics, Inc buyer in Q1 2017 was BlackRock, an estimated $13.9M added.
  • The largest Audentes Therapeutics, Inc seller in Q1 2017 was AllianceBernstein, an estimated $748K sold.

Based on aggregated 13F filings for Q1 2017.